Blog

A new interesting article has been published in Drug Discov Ther. 2020 Mar 26. doi: 10.5582/ddt.2020.01017. [Epub ahead of print] and titled:

Facts and reflections on COVID-19 and anti-hypertensives drugs.

Authors of this article are:

Marin GH.

A summary of the article is shown below:

Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it.

Check out the article’s website on Pubmed for more information:

[link-preview url=https://www.ncbi.nlm.nih.gov/pubmed/32213760 forceshot=true]

This article is a good source of information and a good way to become familiar with topics such as: ACE; ATII-RB; Anti-hypertensive drugs; COVID-19; SARS-CoV-2.

---

New Research Kits from MOLECULAR DEPOT

---

New Antibodies from MOLECULAR DEPOT

---

New Proteins from MOLECULAR DEPOT

---

New Chemicals from MOLECULAR DEPOT